GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Cyclically Adjusted Price-to-FCF

Henan Lingrui Pharmaceutical Co (SHSE:600285) Cyclically Adjusted Price-to-FCF : (As of Apr. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Henan Lingrui Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 168.32 60.24 54.71 28.09 -

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.00 29.53 30.99 - -

Competitive Comparison of Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Henan Lingrui Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Henan Lingrui Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Henan Lingrui Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.068/114.6694*114.6694
=0.068

Current CPI (Mar. 2024) = 114.6694.

Henan Lingrui Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.004 98.200 0.005
201409 0.000 98.900 0.000
201412 0.331 99.000 0.383
201503 0.050 99.900 0.057
201506 0.034 99.500 0.039
201509 0.082 100.500 0.094
201512 0.078 100.600 0.089
201603 -0.048 102.200 -0.054
201606 -0.134 101.400 -0.152
201609 0.003 102.400 0.003
201612 -0.096 102.600 -0.107
201703 -0.125 103.200 -0.139
201706 -0.227 103.100 -0.252
201709 -0.011 104.100 -0.012
201712 0.113 104.500 0.124
201803 0.175 105.300 0.191
201806 0.105 104.900 0.115
201809 0.151 106.600 0.162
201812 0.221 106.500 0.238
201903 0.228 107.700 0.243
201906 0.165 107.700 0.176
201909 0.145 109.800 0.151
201912 0.141 111.200 0.145
202003 0.224 112.300 0.229
202006 0.082 110.400 0.085
202009 0.202 111.700 0.207
202012 0.158 111.500 0.162
202103 0.368 112.662 0.375
202106 0.492 111.769 0.505
202109 0.159 112.215 0.162
202112 0.340 113.108 0.345
202203 0.136 114.335 0.136
202206 0.365 114.558 0.365
202209 0.302 115.339 0.300
202212 0.613 115.116 0.611
202303 0.131 115.116 0.130
202306 0.542 114.558 0.543
202309 0.202 115.339 0.201
202312 0.520 114.669 0.520
202403 0.068 114.669 0.068

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Henan Lingrui Pharmaceutical Co  (SHSE:600285) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Henan Lingrui Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines